354 related articles for article (PubMed ID: 18991182)
1. Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: a randomized controlled trial.
Bjerrum L; Gahrn-Hansen B; Grinsted P
Scand J Prim Health Care; 2009; 27(1):6-11. PubMed ID: 18991182
[TBL] [Abstract][Full Text] [Related]
2. General practitioners do not systematically adhere to regional recommendations on treatment of uncomplicated urinary tract infections.
Christoffersen T; Bjerrum L; Nielsen AB
Dan Med J; 2014 Apr; 61(4):A4814. PubMed ID: 24814591
[TBL] [Abstract][Full Text] [Related]
3. Treatment failures after antibiotic therapy of uncomplicated urinary tract infections. A prescription database study.
Bjerrum L; Dessau RB; Hallas J
Scand J Prim Health Care; 2002 Jun; 20(2):97-101. PubMed ID: 12184721
[TBL] [Abstract][Full Text] [Related]
4. [Prescriptions of a new antibiotic following treatment with sulfamethizole or pivmecillinam].
Bjerrum L; Dessau RB; Hallas J
Ugeskr Laeger; 2003 Sep; 165(39):3732-5. PubMed ID: 14558387
[No Abstract] [Full Text] [Related]
5. Short-term treatment of acute urinary tract infection in girls. Copenhagen Study Group of Urinary Tract Infections in Children.
Scand J Infect Dis; 1991; 23(2):213-20. PubMed ID: 1853170
[TBL] [Abstract][Full Text] [Related]
6. [Sulfamethizole versus pivmecillinam in urinary tract infections].
Frimodt-Møller N
Ugeskr Laeger; 2003 Nov; 165(45):4317; author reply 4317-8. PubMed ID: 14635336
[No Abstract] [Full Text] [Related]
7. Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women.
Nicolle LE; Madsen KS; Debeeck GO; Blochlinger E; Borrild N; Bru JP; Mckinnon C; O'Doherty B; Spiegel W; Van Balen FA; Menday P
Scand J Infect Dis; 2002; 34(7):487-92. PubMed ID: 12195873
[TBL] [Abstract][Full Text] [Related]
8. Pivmecillinam in the treatment of urinary tract infections.
Nicolle LE
J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():35-9; discussion 63-5. PubMed ID: 11051622
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of pivmecillinam: 3 days or 5 days t.i.d against community acquired uncomplicated lower urinary tract infections - a randomized, double-blinded, placebo-controlled clinical trial study protocol.
Jansåker F; Frimodt-Møller N; Bjerrum L; Dahl Knudsen J
BMC Infect Dis; 2016 Dec; 16(1):727. PubMed ID: 27905884
[TBL] [Abstract][Full Text] [Related]
10. Pivmecillinam treatment in acute cystitis. Three versus seven days study.
Pitkäjärvi T; Pyykönen ML; Kannisto K; Piippo T; Viita P
Arzneimittelforschung; 1990 Oct; 40(10):1156-8. PubMed ID: 2291755
[TBL] [Abstract][Full Text] [Related]
11. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women.
Christiaens TC; De Meyere M; Verschraegen G; Peersman W; Heytens S; De Maeseneer JM
Br J Gen Pract; 2002 Sep; 52(482):729-34. PubMed ID: 12236276
[TBL] [Abstract][Full Text] [Related]
12. An open, multi-centre evaluation of a 5-day course of pivmecillinam in urinary tract infections in general practice.
Place C
Pharmatherapeutica; 1981; 3(1):55-60. PubMed ID: 6275417
[TBL] [Abstract][Full Text] [Related]
13. Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections.
Jansåker F; Frimodt-Møller N; Sjögren I; Dahl Knudsen J
J Antimicrob Chemother; 2014 Mar; 69(3):769-72. PubMed ID: 24107388
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of acute urinary infections. Comparison between pivmecillinam for 3 days and sulfamethizole therapy for 6 days].
Bitsch M; Hansen PH; Pagh J
Ugeskr Laeger; 1985 Apr; 147(17):1392-5. PubMed ID: 4002410
[No Abstract] [Full Text] [Related]
15. Pivmecillinam--therapy of choice for lower urinary tract infection.
Graninger W
Int J Antimicrob Agents; 2003 Oct; 22 Suppl 2():73-8. PubMed ID: 14527775
[TBL] [Abstract][Full Text] [Related]
16. Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project.
Ferry SA; Holm SE; Stenlund H; Lundholm R; Monsen TJ
Scand J Prim Health Care; 2007 Mar; 25(1):49-57. PubMed ID: 17354160
[TBL] [Abstract][Full Text] [Related]
17. Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women-A double-blind, randomized non-inferiority trial.
Vik I; Bollestad M; Grude N; Bærheim A; Damsgaard E; Neumark T; Bjerrum L; Cordoba G; Olsen IC; Lindbæk M
PLoS Med; 2018 May; 15(5):e1002569. PubMed ID: 29763434
[TBL] [Abstract][Full Text] [Related]
18. Comparison of pivmecillinam and cephalexin in acute uncomplicated urinary tract infection.
Menday AP
Int J Antimicrob Agents; 2000 Jan; 13(3):183-7. PubMed ID: 10724022
[TBL] [Abstract][Full Text] [Related]
19. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
Ejrnæs K
Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
[TBL] [Abstract][Full Text] [Related]
20. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection.
Stein GE
Clin Ther; 1999 Nov; 21(11):1864-72. PubMed ID: 10890258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
